This episode featuring clinician-scientist and expert in liquid biopsy development, Dr. Lindsey Cotton, who explores the evolving science of lung cancer biomarkers and their role in early detection. Listen in to learn more about the current landscape, benefits and challenges of both organ-specific and multi-cancer tests. The highly informative discussion aims to clarify what these tests can and cannot tell us today, along with a forecast for tomorrow.
Podden och tillhörande omslagsbild på den här sidan tillhör
American Lung Association & HCPLive. Innehållet i podden är skapat av American Lung Association & HCPLive och inte av,
eller tillsammans med, Poddtoppen.
